Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation

Urology Annals

Volumn 7, Issue 2, 2015, Pages 199-204

  Gupta, Neetika ^a   Sureka, Binit ^a   Kumar, Mittal Mahesh ^a   Malik, Amita ^a   Bhushan, Thukral Brij ^a   Mohanty, N K ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

Digits; hand; upper limb; varicose veins; varicosities

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYNDROME DELINEATION; TUMOR DIFFERENTIATION;

EID: 84925295162     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.150480     Document Type: Article

References (28)

1. Barentsz JO, Witjes JA, Ruijs JH. What is new in bladder cancer imaging. Urol Clin North Am 1997;24:583-602.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control 1997;8:346-55.
4. Delclos GL, Lerner SP. Occupational risk factors. Scand J Urol Nephrol Suppl 2008;218:58-63.
5. Nilsson S, Ullén A. Chemotherapy-induced bladder cancer. Scand J Urol Nephrol Suppl 2008; 218:89-92.
6. American Cancer Society. Smoking and Cancer Mortality Table. Table.asp. Published 2009. [Last updated on 2009 Sep 18]. [Last accessed on March 2014]. http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting-smoking-add-res.
7. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009. Available from: http://www.seer.cancer.gov/csr/1975-2006/.[Last Accessed on 2014 Mar 12].
8. Wakui M, Shiigai T. Urinary tract cancer screening through analysis of urinary red blood cell volume distribution. Int J Urol 2000;7:248-53.
9. MacVicar AD. Bladder cancer staging. BJU Int 2000;86 Suppl 1:111-22.
10. Morgan CL, Calkins RF, Cavalcanti EJ. Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate. Radiology 1981;140:751-61.
11. Hodson NJ, Husband JE, MacDonald JS. The role of computed tomography in the staging of bladder cancer. Clin Radiol 1979;30:389-95.
12. Bryan PJ, Butler HE, LiPuma JP, Resnick MI, Kursh ED. CT and MR imaging in staging bladder neoplasms. J Comput Assist Tomogr 1987;11:96-101.
13. Mallampati GK, Siegelman ES. MR imaging of the bladder. Magn Reson Imaging Clin N Am 2004;12:545-55, vii.
14. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: Detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402.
15. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173:393-8.
16. Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, et al. Dynamic MRI of bladder cancer: Evaluation of staging accuracy. AJR Am J Roentgenol 2005;184:121-7.
17. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: How far have we come? CA Cancer J Clin 2010;60:244-72.
18. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: A summary and commentary. Int J Surg Pathol 2005;13:143-53.
19. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, et al. Urinary bladder cancer: Diffusion-weighted MR imaging-Accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251:112-21.
20. Lynch CF, Cohen MB. Urinary system. Cancer 1995;75:316-29.
21. Varkarakis MJ, Gaeta J, Moore RH, Murphy GP. Superficial bladder tumor. Aspects of clinical progression. Urology 1974;4:414-20.
22. Yaman O, Baltaci S, Arikan N, Yilmaz E, Gögüs O. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: Comparison with final pathological stage in invasive bladder carcinoma. Br J Urol 1996;78:197-200.
23. Tuncbilek N, Kaplan M, Altaner S, Atakan IH, Süt N, Inci O, et al. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer. AJR Am J Roentgenol 2009;192:949-55.
24. Buy JN, Moss AA, Guinet C, Ghossain MA, Malbec L, Arrive L, et al. MR staging of bladder carcinoma: Correlation with pathologic findings. Radiology 1988;169:695-700.
25. Tanimoto A, Yuasa Y, Imai Y, Izutsu M, Hiramatsu K, Tachibana M, et al. Bladder tumor staging: Comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 1992;185:741-7.
26. Scattoni V, Da Pozzo LF, Colombo R, Nava L, Rigatti P, De Cobelli F, et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. J Urol 1996;155:1594-9.
27. Husband JE, Olliff JF, Williams MP, Heron CW, Cherryman GR. Bladder cancer: Staging with CT and MR imaging. Radiology 1989;173:435-40.
28. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. Bladder tumor staging: Comparison of contrast-enhanced CT, T1-and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994;193:239-45.